Debio 1562M | Drug Description
Debio 1562M is a next-generation investigational antibody-drug conjugate (ADC) consisting of a humanized monoclonal antibody (K7153B[huCD37-3] or naratuximab) directed against CD37 and conjugated to a peptidic cleavable linker (Multilink™)* bearing a maytansinoid cytotoxic payload (DM1).
Authors
- Peter Hofland (ORCID: https://orcid.org/0000-0002-8025-0434)
Publication Details
- Journal
- ADC Review / Journal of Antibody-drug Conjugates
- Published
- 2025-02-12
- DOI
- https://doi.org/10.14229/jadc.2025.02.12.001
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00